Bausch Health Companies (BHC) Payables (2009 - 2026)

Bausch Health Companies has disclosed Payables across 18 years of filings, most recently posting $593.0 million for Q1 2026.

• Payables for Q1 2026 came in at $593.0 million, down 4.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $593.0 million (down 4.35% YoY), and the FY2025 annual result was $600.0 million, up 1.87% from the prior year.
• Payables came in at $593.0 million for Q1 2026 at Bausch Health Companies, down from $600.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $719.0 million in Q4 2023 to a low of $471.0 million in Q1 2022.
• The 5-year median for Payables is $589.0 million (2024), against an average of $583.0 million.
• Across the five-year window, Payables soared 38.0% in 2023 and slipped 18.08% in 2024, its largest moves.
• Bausch Health Companies' Payables stood at $521.0 million in 2022, then surged by 38.0% to $719.0 million in 2023, then decreased by 18.08% to $589.0 million in 2024, then advanced by 1.87% to $600.0 million in 2025, then declined by 1.17% to $593.0 million in 2026.
• The last three Payables figures came in at $593.0 million (Q1 2026), $600.0 million (Q4 2025), and $616.0 million (Q3 2025), per Business Quant data.